SciClone sales and marketing update

SciClone Pharmaceuticals Inc. (SCLN) The San Mateo, Calif., company said it expects to launch Zadaxin (thymosin alpha 1) to treat chronic hepatitis B in the fourth quarter in Singapore. SCLN said it...